Skip to main content
RayzeBio

Sr Medical Director Clinical Development - Radiopharmaceuticals HCC and GI cancers

RemoteUnited States only
Published
Experience
Senior
Employment
Full-time
$306.8k–$371.8k/yr
Check eligibility

Open to US only. Set where you work from to check your eligibility.

No BS summary

Senior Medical Director leading clinical development of radiopharmaceuticals for HCC and GI cancers. Requires MD with oncology sub-specialty, 5+ years pharma/biotech experience in oncology solid tumor clinical development, and expertise in HCC/GI cancers. Remote US.

What you'll do

  • Interact with clinical investigators and thought leaders to design a clinical development plan for nominated drug candidates
  • Lead internal study teams, and partner with investigators and CROs to design and implement clinical studies
  • Work closely with asset GPLs to ensure development and commercial optimization of RayzeBio assets
  • Contribute to writing of protocols, investigator brochures, clinical study reports, and review of other clinical trial and regulatory documents
  • Conduct investigator meetings and lead site qualification and initiation visits
  • Execute and deploy drug development strategic plans, develop contingency plans, provide technical and strategic advice
  • Translate findings from research and nonclinical studies into clinical development opportunities
  • Oversee Data Review and Independent Data Monitoring Committees
  • Conduct clinical trials using ethical guidelines and ensure compliance
  • Establish and maintain positive relationships with clinical trial investigators and thought leaders
  • Serve as clinical lead for regulatory interactions, including preparation of briefing documents and attendance at health authority meetings
  • Lead cross-functional study teams and collaborate across development and commercial teams
  • Leverage AI to drive program, portfolio, or functional performance
  • Supervise and mentor clinical scientists and junior MDs
  • Willing to travel approximately 30% of the time

What they require

  • MD with sub-specialty training in oncology
  • 5+ years of pharmaceutical/biotech experience in oncology solid tumor clinical development
  • Expertise in HCC and/or GI cancers
  • Experience in all aspects of protocol conduct, including protocol writing, start-up, study execution, analysis, and reporting
  • Experience working closely with investigative sites
  • Solid understanding of GCP and ICH guidelines

Benefits

  • Medical, pharmacy, dental, and vision care
  • Wellbeing programs (BMS Well-Being Account, Living Life Better, EAP)
  • 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, survivor support
  • Flexible time off (unlimited, with manager approval) for US exempt employees
  • 160 hours annual paid vacation for new hires (for Phoenix, AZ, Puerto Rico and RayzeBio exempt/non-exempt/hourly employees)
  • 11 paid national holidays, 3 optional holidays
  • Unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence, annual Global Shutdown

RayzeBio is a wholly-owned subsidiary of Bristol Myers Squibb developing transformative radiopharmaceutical therapies for patients living with cancer.

🇺🇸 United StatesBiotechStartup
$306.8k–$371.8k/yr